Total Payments
$3,315
2024 Payments
$293.54
Companies
21
Transactions
136
Medicare Patients
5,591
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,315 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,315 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,571 | 87 | $0 (2024) |
| Lilly USA, LLC | $394.74 | 10 | $0 (2022) |
| Amgen Inc. | $288.68 | 5 | $0 (2024) |
| Dexcom, Inc. | $288.43 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $140.18 | 2 | $0 (2021) |
| GRT US Holding, Inc. | $125.00 | 1 | $0 (2022) |
| Tandem Diabetes Care, Inc. | $64.30 | 3 | $0 (2024) |
| MannKind Corporation | $49.82 | 2 | $0 (2018) |
| Abbott Laboratories | $49.75 | 3 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $49.65 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.54 | 23 | Novo Nordisk Inc ($176.07) |
| 2023 | $428.33 | 21 | Novo Nordisk Inc ($354.55) |
| 2022 | $866.95 | 37 | Novo Nordisk Inc ($656.35) |
| 2021 | $454.61 | 21 | Novo Nordisk Inc ($353.80) |
| 2019 | $235.54 | 4 | Amgen Inc. ($125.00) |
| 2018 | $670.63 | 18 | Dexcom, Inc. ($173.70) |
| 2017 | $365.13 | 12 | Lilly USA, LLC ($219.76) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Diabetes | ||||||
| 12/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Endocrinology | ||||||
| 04/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.68 | General |
| Category: Diabetes | ||||||
| 02/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Diabetes | ||||||
| 11/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,029 | 9,028 | $1.3M | $516,617 |
| 2022 | 7 | 1,633 | 5,746 | $976,345 | $378,475 |
| 2021 | 9 | 1,109 | 2,112 | $507,546 | $217,418 |
| 2020 | 5 | 820 | 1,687 | $424,070 | $154,085 |
Total Patients
5,591
Total Services
18,573
Medicare Billing
$1.3M
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 908 | 1,725 | $423,660 | $181,450 | 42.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 234 | 3,097 | $247,760 | $115,042 | 46.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 259 | 1,917 | $191,700 | $89,228 | 46.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 244 | 1,652 | $330,400 | $87,518 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 161 | 161 | $60,100 | $23,383 | 38.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 146 | $14,600 | $6,678 | 45.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 83 | $12,450 | $4,933 | 39.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 67 | 145 | $12,772 | $4,232 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,565 | $2,310 | 41.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 90 | 90 | $4,500 | $1,844 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 838 | 1,663 | $408,433 | $173,253 | 42.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 165 | 1,381 | $276,200 | $78,493 | 28.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 135 | 1,292 | $103,360 | $48,541 | 47.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 155 | 1,041 | $104,100 | $48,489 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 196 | 196 | $73,165 | $25,978 | 35.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 35 | 64 | $5,637 | $1,994 | 35.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 109 | 109 | $5,450 | $1,727 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 735 | 1,691 | $415,310 | $182,073 | 43.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 155 | 155 | $57,860 | $22,350 | 38.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 52 | 59 | $11,800 | $4,000 | 33.9% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 19 | 20 | $6,136 | $2,234 | 36.4% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 34 | 38 | $3,800 | $1,883 | 49.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 25 | 47 | $4,140 | $1,521 | 36.8% |
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2021 | 18 | 30 | $2,400 | $1,171 | 48.8% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 19 | 20 | $3,501 | $1,122 | 32.0% |
About Dr. Omar Murad, M.D
Dr. Omar Murad, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fairfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598738015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Murad, M.D has received a total of $3,315 in payments from pharmaceutical and medical device companies, with $293.54 received in 2024. These payments were reported across 136 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,315).
As a Medicare-enrolled provider, Murad has provided services to 5,591 Medicare beneficiaries, totaling 18,573 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine|Endocrinology, Diabetes & Metabolism
- Location Fairfield, CA
- Active Since 02/08/2006
- Last Updated 07/06/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1598738015
Products in Payments
- Ozempic (Drug) $685.13
- Rybelsus (Drug) $632.36
- TRULICITY (Drug) $207.80
- RYBELSUS (Drug) $184.08
- Dexcom CGM (Device) $173.70
- FARXIGA (Drug) $140.18
- HUMULIN (Drug) $134.60
- Prolia (Biological) $128.95
- EVENITY (Biological) $125.00
- Qutenza (Drug) $125.00
- Dexcom G6 Transmitter (Medical Supply) $89.57
- AFREZZA (Drug) $49.82
- t:slim X2 Insulin Pump with Control-IQ (Device) $48.29
- Da Vinci Surgical System (Device) $47.86
- Strensiq (Drug) $45.44
- Omnipod (Device) $41.29
- Sogroya (Biological) $39.20
- TEPEZZA (Biological) $34.73
- BAQSIMI (Drug) $34.34
- Dexcom G5 Mobile CGM System (Device) $25.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Fairfield
Michael Duben, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $24,232
Endocrinology, Diabetes & Metabolism $24,232
Anda Gonciulea, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4,785
Endocrinology, Diabetes & Metabolism $4,785
Dummi Yathiraj, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $496.92
Endocrinology, Diabetes & Metabolism $496.92
John Machledt, Md, MD
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism
Lakshmi Mahali
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism